shares have doubled today on the back a joint venture with Kings College University /Medical Marketing Group of Cambridge to create a novel therapy the to treat the aids/hiv virus.The newly formed company is to named Viritas and will be 50% owned by the Cambridge company.

Very significant statement from MMG today converning viratis aids patents granted in Australia.. and the sp has risen too.

Great article in the Times today which explains why the directors have sold 6.5 million shares to M&G in a private sale as they are a tightly held share and not many shares on the open market..